PRMT5 and neoplasm: Nuclear PRMT5 expression was associated with better outcome of all pulmonary NET; however, it was not independent of tumor type and the observed survival benefit was due to predilection of nuclear PRMT5 to carcinoid tumors exhibiting better prognosis.